Non Serious Adverse Drug Reactions Report

Start Date:2016-08-15 End Date:2016-08-16
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0087Subject Initials :XPTDOB :06/15/1988Sex:FemaleRace:AsianHeight:158cmWeight:57.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 06/02/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Hysteroscopy normalUk-Mar-2015Not on treatment/medication



16-AUG-16
NA/EMR700623-541/C02-0087
Page 1 of41
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-08-15 End Date:2016-08-16
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0102Subject Initials :HYDDOB :10/14/1985Sex:FemaleRace:AsianHeight:163cmWeight:57.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/19/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 06/04/201506/12/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Palace laparoscopy Uk-Unk-2013Not on treatment/medication



16-AUG-16
NA/EMR700623-541/C02-0102
Page 2 of41
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-08-15 End Date:2016-08-16
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0103Subject Initials :CPZDOB :05/12/1989Sex:FemaleRace:AsianHeight:165cmWeight:63.5kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/19/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 06/05/201506/12/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
The right side of the open line on the right side of salpingectomy tubal pregnancy Uk-Unk-2011Not on treatment/medication



15-AUG-16
NA/EMR700623-541/C02-0103
Page 3 of41
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-08-15 End Date:2016-08-16
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0137Subject Initials :YLFDOB :11/01/1989Sex:FemaleRace:AsianHeight:153cmWeight:47.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/22/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/09/201506/16/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
HSG: bilateral tubal obstructionUk-Unk-2014Not on treatment/medication



16-AUG-16
NA/EMR700623-541/C02-0137
Page 4 of41
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-08-15 End Date:2016-08-16
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0138Subject Initials :TTJDOB :06/20/1990Sex:FemaleRace:AsianHeight:150cmWeight:41.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/22/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/06/201506/12/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableNoneResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Ectopic pregnancy laparoscopic surgery: the right fallopian tube embryo pelvic sticking pointsUk-Jan-2014Not on treatment/medication
Hysteroscopy: endometrial polyps.Uk-Feb-2015Not on treatment/medication



15-AUG-16
NA/EMR700623-541/C02-0138
Page 5 of41
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-08-15 End Date:2016-08-16
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0164Subject Initials :AHCDOB :12/12/1982Sex:FemaleRace:AsianHeight:156cmWeight:49.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/26/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/12/201506/20/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
HSG: bilateral tubal occlusion side Uk-Unk-2012Not on treatment/medication
Laparoscopy Surgery: salpingostomy, pelvic adhesions dissection.Uk-Unk-2012Not on treatment/medication



16-AUG-16
NA/EMR700623-541/C02-0164
Page 6 of41
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-08-15 End Date:2016-08-16
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0176Subject Initials :KBFDOB :05/19/1986Sex:FemaleRace:AsianHeight:160cmWeight:57.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/27/2015200
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/11/201506/17/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableNoneResolved
Event Description:OHSS occurs not put embryos
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Tubal examination: passableUk-Unk-2008Not on treatment/medication
HSG: bilateral tubal occlusionUk-Unk-2009Not on treatment/medication
Laparoscopy surgery: bilateral tubal repair plastic surgery, pelvic adhesions dissectionUk-Unk-2011Not on treatment/medication
Ectopic pregnancy: open surgeryUk-Unk-2012Not on treatment/medication



15-AUG-16
NA/EMR700623-541/C02-0176
Page 7 of41
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-08-15 End Date:2016-08-16
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0178Subject Initials :XSCDOB :10/11/1988Sex:FemaleRace:AsianHeight:155cmWeight:54.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/27/2015200
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/10/201506/16/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
HSG: bilateral tubal resistance. Uk-Jan-2013Not on treatment/medication
Laparoscopy surgery: pelvic adhesions dissection, bilateral salpingo-repair plastic surgery, normal uterine shape.Uk-Jan-2013Not on treatment/medication
Hysteroscopy normal, water surgery: incomplete right fallopian tube obstructionUk-Feb-2015Not on treatment/medication



16-AUG-16
NA/EMR700623-541/C02-0178
Page 8 of41
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-08-15 End Date:2016-08-16
Study :EMR700623-541Investigator :NACountry of Investigator :KoreaSiteNo:K01
Subject No :k01-036Subject Initials :JSYDOB :07/28/1981Sex:FemaleRace:AsianHeight:162cmWeight:54g
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment03/13/2015225
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS03/24/201504/07/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Dose not changedConcomitant medication **Resolved
Event Description:
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
ConditionStart DateRelated to study conditionOngoing



16-AUG-16
NA/EMR700623-541/k01-036
Page 9 of41